Cited by 1,823COVID-19 Clinical Research StudiesLong-Term Effects of COVID-19Dermatological and COVID-19 studies

Clinical Characteristics of COVID-19 Patients With Digestive Symptoms in Hubei, China: A Descriptive, Cross-Sectional, Multicenter Study

Open access
Pan, Lei, Mu, Mi, Yang, Pengcheng, Sun, Yu, Wang, Runsheng, Yan, Junhong, Li, Pibao, Hu, Baoguang +10 more·2020·American Journal of Gastroenterology

Abstract

OBJECTIVE: Since the outbreak of Coronavirus Disease 2019 (COVID-19) in December 2019, various digestive symptoms have been frequently reported in patients infected with the virus. In this study, we aimed to further investigate the prevalence and outcomes of COVID-19 patients with digestive symptoms. METHODS: In this descriptive, cross-sectional, multicenter study, we enrolled confirmed patients with COVID-19 who presented to 3 hospitals from January 18, 2020, to February 28, 2020. All patients were confirmed by real-time polymerase chain reaction and were analyzed for clinical characteristics, laboratory data, and treatment. Data were followed up until March 18, 2020. RESULTS: In the present study, 204 patients with COVID-19 and full laboratory, imaging, and historical data were analyzed. The average age was 52.9 years (SD ± 16), including 107 men and 97 women. Although most patients presented to the hospital with fever or respiratory symptoms, we found that 103 patients (50.5%) reported a digestive symptom, including lack of appetite (81 [78.6%] cases), diarrhea (35 [34%] cases), vomiting (4 [3.9%] cases), and abdominal pain (2 [1.9%] cases). If lack of appetite is excluded from the analysis (because it is less specific for the gastrointestinal tract), there were 38 total cases (18.6%) where patients presented with a gastrointestinal-specific symptom, including diarrhea, vomiting, or abdominal pain. Patients with digestive symptoms had a significantly longer time from onset to admission than patients without digestive symptoms (9.0 days vs 7.3 days). In 6 cases, there were digestive symptoms, but no respiratory symptoms. As the severity of the disease increased, digestive symptoms became more pronounced. Patients with digestive symptoms had higher mean liver enzyme levels, lower monocyte count, longer prothrombin time, and received more antimicrobial treatment than those without digestive symptoms. DISCUSSION: We found that digestive symptoms are common in patients with COVID-19. Moreover, these patients have a longer time from onset to admission, evidence of longer coagulation, and higher liver enzyme levels. Clinicians should recognize that digestive symptoms, such as diarrhea, are commonly among the presenting features of COVID-19 and that the index of suspicion may need to be raised earlier in at-risk patients presenting with digestive symptoms. However, further large sample studies are needed to confirm these findings.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.14309/ajg.0000000000000620

Cites

27 of 27 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 1

  1. [7]Cascella M, Rajnik M, Cuomo A, et al. Features, Evaluation and Treatment Coronavirus (COVID-19). StatPearls: Treasure Island, 2020. [Epub ahead of print March 20, 2020]. [Google Scholar]

Cited by

Sorted by citations

Authors
Pan, L., Mu, M., Yang, P., Sun, Y., Wang, R., Yan, J., Li, P., Hu, B., Wang, J., Hu, C., Jin, Y., Niu, X., Ping, R., Du, Y., Li, T., Xu, G., Hu, Q., & Tu, L.
Affiliations
  • Binzhou Medical University (CN)
  • Chinese PLA General Hospital (CN)
  • Renmin Hospital of Wuhan University (CN)
  • Wuhan Union Hospital (CN)
  • Department of Ultrasound, Binzhou Medical University Hospital, Binzhou, China;
  • Department of Critical Care Medicine, Shandong Provincial Third Hospital, Jinan, China;
Corresponding author
  • Hu, Baoguang
  • Hu, Chao
  • Xu, Guogang
  • Hu, Qinyong
  • Tu, Lei
Venue
American Journal of Gastroenterology
Published
2020-04-14
Volume
115
Issue
5
Pages
766-773
ISSN
  • 0002-9270 (ISSN-L)
  • 1572-0241
OpenAlex
W3016131164
Cited by
1,823
References
27
Citations by year
2026: 17 · 2025: 38 · 2024: 104 · 2023: 170 · 2022: 305 · 2021: 530 · 2020: 657 · 2018: 1
FWCI
54.52
Type
journal article
Language
en
Open access
Locations
  • The American Journal of Gastroenterology (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
  • Health Sciences › Medicine › Neurology › Long-Term Effects of COVID-19
  • Health Sciences › Medicine › Dermatology › Dermatological and COVID-19 studies
Keywords
COVID-19 pandemic, gastrointestinal symptoms, diarrhea, vomiting, abdominal pain, appetite loss, disease severity, liver enzymes, coagulopathy, prothrombin time, monocyte count, time to hospital admission, clinical features, Hubei Province
MeSH terms
COVID-19, Adult, Aged, China, Cross-Sectional Studies, Female, Gastrointestinal Diseases, Humans, Male, Middle Aged, Pneumonia, Viral, Prevalence, Treatment Outcome, Coronavirus Infections, Pandemics

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review